{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/6225ecdf5cbe5600122e2dd6/62291f7cb5a8a7001285a4a0?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Capacity disruption, personalized medicines, and pharma investments in 2022","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6225ecdf5cbe5600122e2dd6/1646848316149-2589ad7a9b45eb2d44f496ccd5e64abe.jpeg?height=200","description":"<p>In episode 1 of the World Courier insights podcast, we speak to Jens Mattuschka, World Courier's regional vice president of the Nordics, Central, and Eastern Europe. Jens provides his unique perspectives on capacity disruption due to Omicron, the future of personalized medicines, the importance of control towers, and pharma sector investments in 2022.</p>","author_name":"World Courier"}